Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 09-2007 | 06-2007 | |
| Sales | 1,069 | 1,199 | 1,060 | 1,195 | 997 |
| Cost of Goods | 882 | 833 | 660 | 752 | 741 |
| Gross Profit | 187 | 366 | 399 | 442 | 256 |
| Operating Expenses | 1,764 | 1,825 | 1,175 | 1,186 | 1,120 |
| Operating Income | -695 | -626 | -116 | 9 | -123 |
| Interest Expense | 27 | 7 | 8 | 6 | 7 |
| Other Income | 12 | 12 | 0 | -1 | 17 |
| Pre-tax Income | -710 | -622 | -123 | 1 | -113 |
| Net Income Continuous | -710 | -622 | -123 | 1 | -113 |
| Net Income | $-710 | $-622 | $-123 | $1 | $-113 |
| EPS Basic Total Ops | -0.06 | -0.06 | 0.00 | 0.00 | -0.03 |
| EPS Basic Continuous Ops | -0.07 | -0.06 | -0.01 | 0.00 | -0.02 |
| EPS Diluted Total Ops | -0.06 | -0.06 | 0.00 | 0.00 | -0.03 |
| EPS Diluted Continuous Ops | -0.07 | -0.06 | -0.01 | 0.00 | -0.02 |
| EBITDA(a) | $-600 | $-534 | $-28 | $99 | $-123 |